Cargando…

The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts

INTRODUCTION: Previous studies have shown that the number of myoblastically differentiated fibroblasts known as myofibroblasts (MFs) is significantly increased in stiff joint capsules, indicating their crucial role in the pathogenesis of post-traumatic joint stiffness. Although the mode of MFs'...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattyasovszky, Stefan G, Hofmann, Alexander, Brochhausen, Christoph, Ritz, Ulrike, Kuhn, Sebastian, Wollstädter, Jochen, Schulze-Koops, Hendrik, Müller, Lars P, Watzer, Bernhard, Rommens, Pol M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875629/
https://www.ncbi.nlm.nih.gov/pubmed/20064200
http://dx.doi.org/10.1186/ar2902
_version_ 1782181614270283776
author Mattyasovszky, Stefan G
Hofmann, Alexander
Brochhausen, Christoph
Ritz, Ulrike
Kuhn, Sebastian
Wollstädter, Jochen
Schulze-Koops, Hendrik
Müller, Lars P
Watzer, Bernhard
Rommens, Pol M
author_facet Mattyasovszky, Stefan G
Hofmann, Alexander
Brochhausen, Christoph
Ritz, Ulrike
Kuhn, Sebastian
Wollstädter, Jochen
Schulze-Koops, Hendrik
Müller, Lars P
Watzer, Bernhard
Rommens, Pol M
author_sort Mattyasovszky, Stefan G
collection PubMed
description INTRODUCTION: Previous studies have shown that the number of myoblastically differentiated fibroblasts known as myofibroblasts (MFs) is significantly increased in stiff joint capsules, indicating their crucial role in the pathogenesis of post-traumatic joint stiffness. Although the mode of MFs' function has been well defined for different diseases associated with tissue fibrosis, the underlying mechanisms of their regulation in the pathogenesis of post-traumatic joint capsule contracture are largely unknown. METHODS: In this study, we examined the impact of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) on cellular functions of human joint capsule MFs. MFs were challenged with different concentrations of TNF-α with or without both its specifically inactivating antibody infliximab (IFX) and cyclooxygenase-2 (COX2) inhibitor diclofenac. Cell proliferation, gene expression of both alpha-smooth muscle actin (α-SMA) and collagen type I, the synthesis of prostaglandin derivates E(2), F(1A), and F(2A), as well as the ability to contract the extracellular matrix were assayed in monolayers and in a three-dimensional collagen gel contraction model. The α-SMA and COX2 protein expressions were evaluated by immunofluorescence staining and Western blot analysis. RESULTS: The results indicate that TNF-α promotes cell viability and proliferation of MFs, but significantly inhibits the contraction of the extracellular matrix in a dose-dependent manner. This effect was associated with downregulation of α-SMA and collagen type I by TNF-α application. Furthermore, we found a significant time-dependent upregulation of prostaglandin E(2 )synthesis upon TNF-α treatment. The effect of TNF-α on COX2-positive MFs could be specifically prevented by IFX and partially reduced by the COX2 inhibitor diclofenac. CONCLUSIONS: Our results provide evidence that TNF-α specifically modulates the function of MFs through regulation of prostaglandin E(2 )synthesis and therefore may play a crucial role in the pathogenesis of joint capsule contractures.
format Text
id pubmed-2875629
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28756292010-05-26 The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts Mattyasovszky, Stefan G Hofmann, Alexander Brochhausen, Christoph Ritz, Ulrike Kuhn, Sebastian Wollstädter, Jochen Schulze-Koops, Hendrik Müller, Lars P Watzer, Bernhard Rommens, Pol M Arthritis Res Ther Research article INTRODUCTION: Previous studies have shown that the number of myoblastically differentiated fibroblasts known as myofibroblasts (MFs) is significantly increased in stiff joint capsules, indicating their crucial role in the pathogenesis of post-traumatic joint stiffness. Although the mode of MFs' function has been well defined for different diseases associated with tissue fibrosis, the underlying mechanisms of their regulation in the pathogenesis of post-traumatic joint capsule contracture are largely unknown. METHODS: In this study, we examined the impact of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-α) on cellular functions of human joint capsule MFs. MFs were challenged with different concentrations of TNF-α with or without both its specifically inactivating antibody infliximab (IFX) and cyclooxygenase-2 (COX2) inhibitor diclofenac. Cell proliferation, gene expression of both alpha-smooth muscle actin (α-SMA) and collagen type I, the synthesis of prostaglandin derivates E(2), F(1A), and F(2A), as well as the ability to contract the extracellular matrix were assayed in monolayers and in a three-dimensional collagen gel contraction model. The α-SMA and COX2 protein expressions were evaluated by immunofluorescence staining and Western blot analysis. RESULTS: The results indicate that TNF-α promotes cell viability and proliferation of MFs, but significantly inhibits the contraction of the extracellular matrix in a dose-dependent manner. This effect was associated with downregulation of α-SMA and collagen type I by TNF-α application. Furthermore, we found a significant time-dependent upregulation of prostaglandin E(2 )synthesis upon TNF-α treatment. The effect of TNF-α on COX2-positive MFs could be specifically prevented by IFX and partially reduced by the COX2 inhibitor diclofenac. CONCLUSIONS: Our results provide evidence that TNF-α specifically modulates the function of MFs through regulation of prostaglandin E(2 )synthesis and therefore may play a crucial role in the pathogenesis of joint capsule contractures. BioMed Central 2010 2010-01-08 /pmc/articles/PMC2875629/ /pubmed/20064200 http://dx.doi.org/10.1186/ar2902 Text en Copyright ©2010 Mattyasovszky et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Mattyasovszky, Stefan G
Hofmann, Alexander
Brochhausen, Christoph
Ritz, Ulrike
Kuhn, Sebastian
Wollstädter, Jochen
Schulze-Koops, Hendrik
Müller, Lars P
Watzer, Bernhard
Rommens, Pol M
The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
title The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
title_full The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
title_fullStr The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
title_full_unstemmed The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
title_short The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
title_sort effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875629/
https://www.ncbi.nlm.nih.gov/pubmed/20064200
http://dx.doi.org/10.1186/ar2902
work_keys_str_mv AT mattyasovszkystefang theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT hofmannalexander theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT brochhausenchristoph theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT ritzulrike theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT kuhnsebastian theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT wollstadterjochen theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT schulzekoopshendrik theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT mullerlarsp theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT watzerbernhard theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT rommenspolm theeffectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT mattyasovszkystefang effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT hofmannalexander effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT brochhausenchristoph effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT ritzulrike effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT kuhnsebastian effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT wollstadterjochen effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT schulzekoopshendrik effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT mullerlarsp effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT watzerbernhard effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts
AT rommenspolm effectoftheproinflammatorycytokinetumornecrosisfactoralphaonhumanjointcapsulemyofibroblasts